183 related articles for article (PubMed ID: 29558451)
21. Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells.
Bressler EM; Kim J; Shmueli RB; Mirando AC; Bazzazi H; Lee E; Popel AS; Pandey NB; Green JJ
J Biomed Mater Res A; 2018 Jun; 106(6):1753-1764. PubMed ID: 29424479
[TBL] [Abstract][Full Text] [Related]
22. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
23. [Research on Tat peptide-polyethylene glycol modified gelatin-siloxane nanoparticles across the blood-brain barrier].
Tian X; Wei F; Lin X; Feng W; Wang P
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Jun; 29(3):486-90, 500. PubMed ID: 22826945
[TBL] [Abstract][Full Text] [Related]
24. Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles.
Rangger C; Helbok A; von Guggenberg E; Sosabowski J; Radolf T; Prassl R; Andreae F; Thurner GC; Haubner R; Decristoforo C
Int J Nanomedicine; 2012; 7():5889-900. PubMed ID: 23226020
[TBL] [Abstract][Full Text] [Related]
25. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
[TBL] [Abstract][Full Text] [Related]
26. Competition of charge-mediated and specific binding by peptide-tagged cationic liposome-DNA nanoparticles in vitro and in vivo.
Wonder E; Simón-Gracia L; Scodeller P; Majzoub RN; Kotamraju VR; Ewert KK; Teesalu T; Safinya CR
Biomaterials; 2018 Jun; 166():52-63. PubMed ID: 29544111
[TBL] [Abstract][Full Text] [Related]
27. Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide.
Guerrero S; Araya E; Fiedler JL; Arias JI; Adura C; Albericio F; Giralt E; Arias JL; Fernández MS; Kogan MJ
Nanomedicine (Lond); 2010 Aug; 5(6):897-913. PubMed ID: 20735225
[TBL] [Abstract][Full Text] [Related]
28. Optimal method of gold nanoparticle administration in melanoma-bearing mice.
Komatsu T; Nakamura K; Okumura Y; Konishi K
Exp Ther Med; 2018 Mar; 15(3):2994-2999. PubMed ID: 29456704
[TBL] [Abstract][Full Text] [Related]
29. Modeling of nanoparticle transport through the female reproductive tract for the treatment of infectious diseases.
Sims LB; Miller HA; Halwes ME; Steinbach-Rankins JM; Frieboes HB
Eur J Pharm Biopharm; 2019 May; 138():37-47. PubMed ID: 30195726
[TBL] [Abstract][Full Text] [Related]
30. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
31. Prostate Cancer Targeted X-Ray Fluorescence Imaging via Gold Nanoparticles Functionalized With Prostate-Specific Membrane Antigen (PSMA).
Hara D; Tao W; Totiger TM; Pourmand A; Dogan N; Ford JC; Shi J; Pollack A
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):220-232. PubMed ID: 33964351
[TBL] [Abstract][Full Text] [Related]
32. Incorporation of Low Concentrations of Gold Nanoparticles: Complex Effects on Radiation Response and Fate of Cancer Cells.
Dobešová L; Gier T; Kopečná O; Pagáčová E; Vičar T; Bestvater F; Toufar J; Bačíková A; Kopel P; Fedr R; Hildenbrand G; Falková I; Falk M; Hausmann M
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057061
[No Abstract] [Full Text] [Related]
33. Engineering and Validation of a Peptide-Stabilized Poly(lactic-
Dragulska SA; Poursharifi M; Chen Y; Wlodarczyk MT; Acosta Santiago M; Dottino P; Martignetti JA; Mieszawska AJ
Bioconjug Chem; 2022 Dec; 33(12):2348-2360. PubMed ID: 36367382
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
[TBL] [Abstract][Full Text] [Related]
35. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
36. Effects of bisphosphonate ligands and PEGylation on targeted delivery of gold nanoparticles for contrast-enhanced radiographic detection of breast microcalcifications.
Cole LE; McGinnity TL; Irimata LE; Vargo-Gogola T; Roeder RK
Acta Biomater; 2018 Dec; 82():122-132. PubMed ID: 30316022
[TBL] [Abstract][Full Text] [Related]
37. Enhanced and selective permeability of gold nanoparticles functionalized with cell penetrating peptide derived from maurocalcine animal toxin.
Khamehchian S; Nikkhah M; Madani R; Hosseinkhani S
J Biomed Mater Res A; 2016 Nov; 104(11):2693-700. PubMed ID: 27324825
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric effects of polyethylene glycol surface coatings on gold nanoparticle radiosensitization.
Koger B; Kirkby C
Phys Med Biol; 2017 Oct; 62(21):8455-8469. PubMed ID: 28933351
[TBL] [Abstract][Full Text] [Related]
39. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
